Abstract
One attractive strategy to prevent or control allograft rejection is to genetically modify the donor tissue before transplantation. In this study, we have examined the feasibility of gene transfer to human corneal endothelium, using a number of recombinant adenovirus constructs. Ex vivo infection of human corneas with adenoviral vectors containing lacZ, under transcriptional control of either cytomegalovirus (CMV) or Rous sarcoma virus (RSV) promoters, provided high-level gene expression, which was largely restricted to endothelium. Expression of the reporter gene persisted at relatively high levels for up to 7 days, followed by a decline to indetectable levels by 28 days. RT-PCR analysis of lacZ transcription showed a similar picture with a short period (3–7 days) of RNA transcription after infection. In contrast, adenoviral DNA persisted for at least 56 days. Subsequently, we examined the expression of a potential therapeutic gene, CTLA-4 Ig fusion protein. Following infection of human corneas with adenoviral vectors encoding CTLA-4 Ig protein, high levels of the fusion protein were detected in corneal culture supernatants for up to 28 days. This protein was functionally active, as determined by binding to B7.1 (CD80)-expressing transfectants. This study suggests that genetic alteration of donor cornea before transplantation is a feasible approach for preventing or controlling allograft rejection. Similar gene-based strategies might also be feasible to prevent rejection of other transplanted tissues or organs.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oral, H., Larkin, D., Fehervari, Z. et al. Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea. Gene Ther 4, 639–647 (1997). https://doi.org/10.1038/sj.gt.3300443
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300443
- Springer Nature Limited
Keywords
This article is cited by
-
100 Jahre erfolgreiche Hornhauttransplantation
Spektrum der Augenheilkunde (2007)
-
Prospects for gene therapy in corneal disease
Eye (2003)
-
Ocular transfer of retinal glial cells transduced ex vivo with adenovirus expressing viral IL-10 or CTLA4-Ig inhibits experimental autoimmune uveoretinitis
Gene Therapy (2003)
-
Prolonged organ retention and safety of plasmid DNA administered in polyethylenimine complexes
Gene Therapy (2001)
-
Efficient and sustained transgene expression in human corneal cells mediated by a lentiviral vector
Gene Therapy (2000)